InPoint Commercial Real Estate Income (ICR-PA) Net Margin Growth (1y) (2018 - 2026)
Powered by 
Analysis
InPoint Commercial Real Estate Income (ICR-PA) Net Margin Growth (1y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Orix | 43.85 Bn | 43.85 Bn | 4.68 Bn | 1,767.00 |
| 2 | Royalty Pharma | 26.83 Bn | 26.00 Bn | - | -392.00 |
| 3 | Royal Gold | 22.18 Bn | 22.00 Bn | 390.45 Mn | -1,046.00 |
| 4 | OR Royalties | 6.95 Bn | 6.88 Bn | 82.22 Mn | 1,233.00 |
| 5 | Encore Capital | 2.13 Bn | 1.95 Bn | 455.04 Mn | -27.00 |
| 6 | Atlanticus Holdings | 1.42 Bn | 866.02 Mn | 686.46 Mn | -82.00 |
| 7 | Jefferson Capital | 1.20 Bn | 1.18 Bn | - | -794.00 |
| 8 | Upbound | 1.08 Bn | 973.35 Mn | 594.84 Mn | 52.00 |
| 9 | Lufax Holding | 1.07 Bn | -1.56 Bn | - | -144.00 |
| 10 | InPoint Commercial Real Estate Income | 226.28 Mn | 167.15 Mn | - | -9,880.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9,880.00 |
| Mar 31, 2026 | -15,142.00 |
| Dec 31, 2025 | -7,339.00 |
| Sep 30, 2025 | -16,128.00 |
| Jun 30, 2025 | -3,549.00 |
| Mar 31, 2025 | 861.00 |
| Dec 31, 2024 | 3,640.00 |
| Sep 30, 2024 | -4,497.00 |
| Jun 30, 2024 | 20,294.00 |
| Mar 31, 2024 | 82.00 |
| Dec 31, 2023 | 279.00 |
| Sep 30, 2023 | 783.00 |
| Jun 30, 2023 | -15,945.00 |
| Mar 31, 2023 | 2,186.00 |
| Dec 31, 2022 | -1,907.00 |
| Sep 30, 2022 | -854.00 |
| Jun 30, 2022 | -3,035.00 |
| Mar 31, 2022 | -1,405.00 |
| Dec 31, 2018 | -6,304.00 |
| Sep 30, 2018 | 7,314.00 |